-
1
-
-
33751297349
-
Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression
-
Nov 1
-
Lee J, Park SY, Lee EK, et al. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res. Nov 1 2006;12(21):6351-6358.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.21
, pp. 6351-6358
-
-
Lee, J.1
Park, S.Y.2
Lee, E.K.3
-
2
-
-
35348969719
-
Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: Their inhibition by resveratrol
-
Dec 8
-
Park SY, Jeong KJ, Lee J, et al. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett. Dec 8 2007;258(1):63-69.
-
(2007)
Cancer Lett
, vol.258
, Issue.1
, pp. 63-69
-
-
Park, S.Y.1
Jeong, K.J.2
Lee, J.3
-
3
-
-
33846840798
-
SPARC inhibits LPAmediated mesothelial-ovarian cancer cell crosstalk
-
Jan
-
Said NA, Najwer I, Socha MJ, Fulton DJ, Mok SC, Motamed K. SPARC inhibits LPAmediated mesothelial-ovarian cancer cell crosstalk. Neoplasia. Jan 2007;9(1):23-35.
-
(2007)
Neoplasia
, vol.9
, Issue.1
, pp. 23-35
-
-
Said, N.A.1
Najwer, I.2
Socha, M.J.3
Fulton, D.J.4
Mok, S.C.5
Motamed, K.6
-
4
-
-
0032569235
-
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
-
Aug 26
-
Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. Aug 26 1998;280(8):719-723.
-
(1998)
JAMA
, vol.280
, Issue.8
, pp. 719-723
-
-
Xu, Y.1
Shen, Z.2
Wiper, D.W.3
-
5
-
-
0037134949
-
Plasma lysophosphatidic acid concentration and ovarian cancer
-
Jun 19
-
Baker DL, Morrison P, Miller B, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. Jun 19 2002;287(23):3081-3082.
-
(2002)
JAMA
, vol.287
, Issue.23
, pp. 3081-3082
-
-
Baker, D.L.1
Morrison, P.2
Miller, B.3
-
6
-
-
3142660497
-
Lysophospholipids are potential biomarkers of ovarian cancer
-
Jul
-
Sutphen R, Xu Y, Wilbanks GD, et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev. Jul 2004;13(7):1185-1191.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, Issue.7
, pp. 1185-1191
-
-
Sutphen, R.1
Xu, Y.2
Wilbanks, G.D.3
-
7
-
-
0042887042
-
The emerging role of lysophosphatidic acid in cancer
-
Aug
-
Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer. Aug 2003;3(8):582-591.
-
(2003)
Nat Rev Cancer
, vol.3
, Issue.8
, pp. 582-591
-
-
Mills, G.B.1
Moolenaar, W.H.2
-
8
-
-
33845343972
-
Of spiders and crabs: The emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer
-
Nov 15
-
Murph M, Tanaka T, Liu S, Mills GB. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. Clin Cancer Res. Nov 15 2006;12(22):6598-6602.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.22
, pp. 6598-6602
-
-
Murph, M.1
Tanaka, T.2
Liu, S.3
Mills, G.B.4
-
9
-
-
34247860781
-
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acidinduced cell invasion
-
May 3
-
Sengupta S, Kim KS, Berk MP, et al. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acidinduced cell invasion. Oncogene. May 3 2007;26(20):2894- 2901.
-
(2007)
Oncogene
, vol.26
, Issue.20
, pp. 2894-2901
-
-
Sengupta, S.1
Kim, K.S.2
Berk, M.P.3
-
10
-
-
33645525087
-
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
-
Mar 15
-
Ren J, Xiao YJ, Singh LS, et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. Mar 15 2006;66(6):3006-3014.
-
(2006)
Cancer Res
, vol.66
, Issue.6
, pp. 3006-3014
-
-
Ren, J.1
Xiao, Y.J.2
Singh, L.S.3
-
11
-
-
33748056087
-
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo
-
Aug 15
-
Kim KS, Sengupta S, Berk M, et al. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. Aug 15 2006;66(16):7983-7990.
-
(2006)
Cancer Res
, vol.66
, Issue.16
, pp. 7983-7990
-
-
Kim, K.S.1
Sengupta, S.2
Berk, M.3
-
12
-
-
40949146034
-
Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells
-
Mar
-
Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD. Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells. Mol Cancer Res. Mar 2008;6(3):352-363.
-
(2008)
Mol Cancer Res
, vol.6
, Issue.3
, pp. 352-363
-
-
Ptaszynska, M.M.1
Pendrak, M.L.2
Bandle, R.W.3
Stracke, M.L.4
Roberts, D.D.5
-
13
-
-
0037374562
-
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: Validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer
-
Mar 1
-
Tanyi JL, Morris AJ, Wolf JK, et al. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res. Mar 1 2003;63(5):1073-1082.
-
(2003)
Cancer Res
, vol.63
, Issue.5
, pp. 1073-1082
-
-
Tanyi, J.L.1
Morris, A.J.2
Wolf, J.K.3
-
14
-
-
12444267437
-
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
-
Sep 1
-
Tanyi JL, Hasegawa Y, Lapushin R, et al. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin Cancer Res. Sep 1 2003;9(10 Pt 1):3534-3545.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.10 PART 1
, pp. 3534-3545
-
-
Tanyi, J.L.1
Hasegawa, Y.2
Lapushin, R.3
-
15
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
Feb
-
Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. Feb 1997;18(1):4-25.
-
(1997)
Endocr Rev
, vol.18
, Issue.1
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
16
-
-
0035897531
-
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
-
May 16
-
Hu YL, Tee MK, Goetzl EJ, et al. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst. May 16 2001;93(10):762-768.
-
(2001)
J Natl Cancer Inst
, vol.93
, Issue.10
, pp. 762-768
-
-
Hu, Y.L.1
Tee, M.K.2
Goetzl, E.J.3
-
17
-
-
20444471030
-
LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGFR2
-
Jun
-
So J, Wang FQ, Navari J, Schreher J, Fishman DA. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGFR2). Gynecol Oncol. Jun 2005;97(3):870-878.
-
(2005)
Gynecol Oncol
, vol.97
, Issue.3
, pp. 870-878
-
-
So, J.1
Wang, F.Q.2
Navari, J.3
Schreher, J.4
Fishman, D.A.5
-
18
-
-
0024421453
-
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
-
Oct
-
Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. Oct 1989;84(4):1045-1049.
-
(1989)
J Clin Invest
, vol.84
, Issue.4
, pp. 1045-1049
-
-
Baggiolini, M.1
Walz, A.2
Kunkel, S.L.3
-
19
-
-
0032409134
-
The chemotactic cytokine interleukin-8-a cyst fluid marker for malignant epithelial ovarian cancer?
-
Dec
-
Ivarsson K, Runesson E, Sundfeldt K, et al. The chemotactic cytokine interleukin-8-a cyst fluid marker for malignant epithelial ovarian cancer? Gynecol Oncol. Dec 1998;71(3):420-423.
-
(1998)
Gynecol Oncol
, vol.71
, Issue.3
, pp. 420-423
-
-
Ivarsson, K.1
Runesson, E.2
Sundfeldt, K.3
-
20
-
-
0035025317
-
Lysophospholipids increase interleukin-8 expression in ovarian cancer cells
-
May
-
Schwartz BM, Hong G, Morrison BH, et al. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. Gynecol Oncol. May 2001;81(2):291-300.
-
(2001)
Gynecol Oncol
, vol.81
, Issue.2
, pp. 291-300
-
-
Schwartz, B.M.1
Hong, G.2
Morrison, B.H.3
-
21
-
-
10744225477
-
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
-
Mar 5
-
Fang X, Yu S, Bast RC, et al. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem. Mar 5 2004;279(10):9653-9661.
-
(2004)
J Biol Chem
, vol.279
, Issue.10
, pp. 9653-9661
-
-
Fang, X.1
Yu, S.2
Bast, R.C.3
-
22
-
-
7444230423
-
Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8
-
Nov
-
So J, Navari J, Wang FQ, Fishman DA. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol. Nov 2004;95(2):314-322.
-
(2004)
Gynecol Oncol
, vol.95
, Issue.2
, pp. 314-322
-
-
So, J.1
Navari, J.2
Wang, F.Q.3
Fishman, D.A.4
-
23
-
-
15444368022
-
Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells
-
Li H, Ye X, Mahanivong C, Bian D, Chun J, Huang S. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem. Mar 18 2005;280(11):10564- 10571.
-
(2005)
J Biol Chem. Mar 18
, vol.280
, Issue.11
, pp. 10564-10571
-
-
Li, H.1
Ye, X.2
Mahanivong, C.3
Bian, D.4
Chun, J.5
Huang, S.6
-
24
-
-
0034892043
-
Increased expression of matrix metalloproteinases (MMP)-2 MMP-9 and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
-
Aug
-
Schmalfeldt B, Prechtel D, Harting K, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res. Aug 2001;7(8):2396-2404.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.8
, pp. 2396-2404
-
-
Schmalfeldt, B.1
Prechtel, D.2
Harting, K.3
-
25
-
-
0742307276
-
Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression
-
Jan
-
Murthi P, Barker G, Nowell CJ, et al. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression. Gynecol Oncol. Jan 2004;92(1):80-88.
-
(2004)
Gynecol Oncol
, vol.92
, Issue.1
, pp. 80-88
-
-
Murthi, P.1
Barker, G.2
Nowell, C.J.3
-
26
-
-
0033179049
-
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type- plasminogen-activator N-terminal fragment
-
Aug 1
-
Fishman DA, Kearns A, Larsh S, Enghild JJ, Stack MS. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment. Biochem J. Aug 1 1999;341 ( Pt 3):765-769.
-
(1999)
Biochem J
, vol.341
, Issue.PART 3
, pp. 765-769
-
-
Fishman, D.A.1
Kearns, A.2
Larsh, S.3
Enghild, J.J.4
Stack, M.S.5
-
27
-
-
0035910565
-
Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways
-
Jan 19
-
Kobayashi H, Suzuki M, Tanaka Y, Hirashima Y, Terao T. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem. Jan 19 2001;276(3):2015-2022.
-
(2001)
J Biol Chem
, vol.276
, Issue.3
, pp. 2015-2022
-
-
Kobayashi, H.1
Suzuki, M.2
Tanaka, Y.3
Hirashima, Y.4
Terao, T.5
-
28
-
-
0037174147
-
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread
-
Sep 25
-
Sato S, Kopitz C, Schmalix WA, et al. High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread. FEBS Lett. Sep 25 2002;528(1-3):212-216.
-
(2002)
FEBS Lett
, vol.528
, Issue.1-3
, pp. 212-216
-
-
Sato, S.1
Kopitz, C.2
Schmalix, W.A.3
-
29
-
-
0037431429
-
Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin
-
Apr 10
-
Suzuki M, Kobayashi H, Tanaka Y, et al. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer. Apr 10 2003;104(3):289-302.
-
(2003)
Int J Cancer
, vol.104
, Issue.3
, pp. 289-302
-
-
Suzuki, M.1
Kobayashi, H.2
Tanaka, Y.3
-
30
-
-
0032712996
-
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
-
Nov
-
Pustilnik TB, Estrella V, Wiener JR, et al. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. Nov 1999;5(11):3704-3710.
-
(1999)
Clin Cancer Res
, vol.5
, Issue.11
, pp. 3704-3710
-
-
Pustilnik, T.B.1
Estrella, V.2
Wiener, J.R.3
-
31
-
-
0942301169
-
Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)
-
Jan 8
-
Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek CJ, Goetzl EJ. Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene. Jan 8 2004;23(1):122-129.
-
(2004)
Oncogene
, vol.23
, Issue.1
, pp. 122-129
-
-
Huang, M.C.1
Lee, H.Y.2
Yeh, C.C.3
Kong, Y.4
Zaloudek, C.J.5
Goetzl, E.J.6
-
32
-
-
39749123870
-
Protein kinase C alpha- CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells
-
Feb 21
-
Mahanivong C, Chen HM, Yee SW, Pan ZK, Dong Z, Huang S. Protein kinase C alpha- CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene. Feb 21 2008;27(9):1273-1280.
-
(2008)
Oncogene
, vol.27
, Issue.9
, pp. 1273-1280
-
-
Mahanivong, C.1
Chen, H.M.2
Yee, S.W.3
Pan, Z.K.4
Dong, Z.5
Huang, S.6
-
33
-
-
35148887739
-
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway
-
Aug
-
Estrella VC, Eder AM, Liu S, et al. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway. Int J Oncol. Aug 2007;31(2):441-449.
-
(2007)
Int J Oncol
, vol.31
, Issue.2
, pp. 441-449
-
-
Estrella, V.C.1
Eder, A.M.2
Liu, S.3
-
34
-
-
38649131972
-
Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner
-
Feb
-
Gil OD, Lee C, Ariztia EV, et al. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol Oncol. Feb 2008;108(2):361-369.
-
(2008)
Gynecol Oncol
, vol.108
, Issue.2
, pp. 361-369
-
-
Gil, O.D.1
Lee, C.2
-
35
-
-
0036716282
-
Strategies for MMP inhibition in cancer: Innovations for the post-trial era
-
Sep
-
Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. Sep 2002;2(9):657-672.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.9
, pp. 657-672
-
-
Overall, C.M.1
Lopez-Otin, C.2
-
36
-
-
0033119050
-
Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin
-
Apr 1
-
Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, Stack MS. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res. Apr 1 1999;59(7):1635- 1641.
-
(1999)
Cancer Res
, vol.59
, Issue.7
, pp. 1635-1641
-
-
Ellerbroek, S.M.1
Fishman, D.A.2
Kearns, A.S.3
Bafetti, L.M.4
Stack, M.S.5
-
37
-
-
0033762457
-
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
-
Davidson B, Goldberg I, Gotlieb WH, et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis. 1999;17(10):799-808.
-
(1999)
Clin Exp Metastasis
, vol.17
, Issue.10
, pp. 799-808
-
-
Davidson, B.1
Goldberg, I.2
Gotlieb, W.H.3
-
38
-
-
0037036679
-
Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice
-
Aug 7
-
Huang S, Van Arsdall M, Tedjarati S, et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst. Aug 7 2002;94(15):1134-1142.
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.15
, pp. 1134-1142
-
-
Huang, S.1
Van Arsdall, M.2
Tedjarati, S.3
-
39
-
-
0031985228
-
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
-
Jan 9
-
Butler GS, Butler MJ, Atkinson SJ, et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem. Jan 9 1998;273(2):871-880.
-
(1998)
J Biol Chem
, vol.273
, Issue.2
, pp. 871-880
-
-
Butler, G.S.1
Butler, M.J.2
Atkinson, S.J.3
-
40
-
-
0030435159
-
Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells
-
Fishman DA, Bafetti LM, Stack MS. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis. 1996;16(3):150-159.
-
(1996)
Invasion Metastasis
, vol.16
, Issue.3
, pp. 150-159
-
-
Fishman, D.A.1
Bafetti, L.M.2
Stack, M.S.3
-
41
-
-
0035300534
-
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
-
Apr 1
-
Fishman DA, Liu Y, Ellerbroek SM, Stack MS. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. Apr 1 2001;61(7):3194-3199.
-
(2001)
Cancer Res
, vol.61
, Issue.7
, pp. 3194-3199
-
-
Fishman, D.A.1
Liu, Y.2
Ellerbroek, S.M.3
Stack, M.S.4
-
42
-
-
16844378151
-
Cyclooxygenase- 2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
-
Mar 15
-
Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase- 2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res. Mar 15 2005;65(6):2234-2242.
-
(2005)
Cancer Res
, vol.65
, Issue.6
, pp. 2234-2242
-
-
Symowicz, J.1
Adley, B.P.2
Woo, M.M.3
Auersperg, N.4
Hudson, L.G.5
Stack, M.S.6
-
43
-
-
33947215647
-
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells
-
Feb
-
Do TV, Symowicz JC, Berman DM, et al. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Mol Cancer Res. Feb 2007;5(2):121-131.
-
(2007)
Mol Cancer Res
, vol.5
, Issue.2
, pp. 121-131
-
-
Do, T.V.1
Symowicz, J.C.2
Berman, D.M.3
-
44
-
-
33845308614
-
Inhibition of matrilysin expression by antisense orRNAinterference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion
-
Nov
-
Wang FQ, Smicun Y, Calluzzo N, Fishman DA. Inhibition of matrilysin expression by antisense orRNAinterference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion. Mol Cancer Res. Nov 2006;4(11):831-841.
-
(2006)
Mol Cancer Res
, vol.4
, Issue.11
, pp. 831-841
-
-
Wang, F.Q.1
Smicun, Y.2
Calluzzo, N.3
Fishman, D.A.4
-
45
-
-
0038581051
-
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
-
May 15
-
Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. May 15 2003;22(10):2411-2421.
-
(2003)
EMBO J
, vol.22
, Issue.10
, pp. 2411-2421
-
-
Gschwind, A.1
Hart, S.2
Fischer, O.M.3
Ullrich, A.4
-
46
-
-
0036157485
-
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer
-
Mar
-
Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol. Mar 2002;190(3):279-286.
-
(2002)
J Cell Physiol
, vol.190
, Issue.3
, pp. 279-286
-
-
Cao, Y.1
Prescott, S.M.2
-
47
-
-
0025905264
-
Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463
-
Jun
-
Butler TA, Zhu C, Mueller RA, Fuller GC, Lemaire WJ, Woessner JF, Jr. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol Reprod. Jun 1991;44(6):1183-1188.
-
(1991)
Biol Reprod
, vol.44
, Issue.6
, pp. 1183-1188
-
-
Butler, T.A.1
Zhu, C.2
Mueller, R.A.3
Fuller, G.C.4
Lemaire, W.J.5
Woessner Jr., J.F.6
-
48
-
-
0035476888
-
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages
-
Oct 1
-
Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. Oct 1 2001;61(19):7305-7309.
-
(2001)
Cancer Res
, vol.61
, Issue.19
, pp. 7305-7309
-
-
Klimp, A.H.1
Hollema, H.2
Kempinga, C.3
Van Der Zee, A.G.4
De Vries, E.G.5
Daemen, T.6
-
49
-
-
0033569884
-
Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors
-
Oct 15
-
Ershov AV, Bazan NG. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors. J Neurosci Res. Oct 15 1999;58(2):254-261.
-
(1999)
J Neurosci Res
, vol.58
, Issue.2
, pp. 254-261
-
-
Ershov, A.V.1
Bazan, N.G.2
-
50
-
-
0036359548
-
Hypoxia-a key regulatory factor in tumour growth
-
Jan
-
Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer. Jan 2002;2(1):38-47.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.1
, pp. 38-47
-
-
Harris, A.L.1
-
51
-
-
2542569400
-
Hypoxia-inducible factor 1 (HIF-1) in cancer
-
Jun
-
Quintero M, Mackenzie N, Brennan PA. Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol. Jun 2004;30(5):465-468.
-
(2004)
Eur J Surg Oncol
, vol.30
, Issue.5
, pp. 465-468
-
-
Quintero, M.1
MacKenzie, N.2
Brennan, P.A.3
-
52
-
-
33747685338
-
PR92 as a new G12/13- and Gqcoupled lysophosphatidic acid receptor that increases cAMP, LPA5
-
Aug 18
-
Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. PR92 as a new G12/13- and Gqcoupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem. Aug 18 2006;281(33):23589-23597.
-
(2006)
J Biol Chem
, vol.281
, Issue.33
, pp. 23589-23597
-
-
Lee, C.W.1
Rivera, R.2
Gardell, S.3
Dubin, A.E.4
Chun, J.5
-
53
-
-
75149125139
-
A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation
-
Dec 5
-
Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta. Dec 5 2007.
-
(2007)
Biochim Biophys Acta
-
-
Shano, S.1
Hatanaka, K.2
Ninose, S.3
Moriyama, R.4
Tsujiuchi, T.5
Fukushima, N.6
-
54
-
-
37549037081
-
Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells
-
Feb
-
Hurst JH, Henkel PA, Brown AL, Hooks SB. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells. Cell Signal. Feb 2008;20(2):381-389.
-
(2008)
Cell Signal
, vol.20
, Issue.2
, pp. 381-389
-
-
Hurst, J.H.1
Henkel, P.A.2
Brown, A.L.3
Hooks, S.B.4
-
55
-
-
77953675159
-
Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells
-
Nov 20
-
Lee MJ, Jeon ES, Lee JS, et al. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells. J Cell Biochem. Nov 20 2007.
-
(2007)
J Cell Biochem
-
-
Lee, M.J.1
Jeon, E.S.2
Lee, J.S.3
-
56
-
-
0033043251
-
Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)
-
Jun 11
-
Mukai M, Imamura F, Ayaki M, et al. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Int J Cancer. Jun 11 1999;81(6):918-922.
-
(1999)
Int J Cancer
, vol.81
, Issue.6
, pp. 918-922
-
-
Mukai, M.1
Imamura, F.2
Ayaki, M.3
-
57
-
-
0032697808
-
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
-
Oct 15
-
Goetzl EJ, Dolezalova H, Kong Y, et al. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. Oct 15 1999;59(20):5370-5375.
-
(1999)
Cancer Res
, vol.59
, Issue.20
, pp. 5370-5375
-
-
Goetzl, E.J.1
Dolezalova, H.2
Kong, Y.3
-
58
-
-
0347520943
-
Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1
-
Jan 3
-
Van Leeuwen FN, Olivo C, Grivell S, Giepmans BN, Collard JG, Moolenaar WH. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J Biol Chem. Jan 3 2003;278(1):400-406.
-
(2003)
J Biol Chem
, vol.278
, Issue.1
, pp. 400-406
-
-
Van Leeuwen, F.N.1
Olivo, C.2
Grivell, S.3
Giepmans, B.N.4
Collard, J.G.5
Moolenaar, W.H.6
-
59
-
-
0036931306
-
Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells
-
Dec
-
Sawada K, Morishige K, Tahara M, et al. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells. Gynecol Oncol. Dec 2002;87(3):252-259.
-
(2002)
Gynecol Oncol
, vol.87
, Issue.3
, pp. 252-259
-
-
Sawada, K.1
Morishige, K.2
Tahara, M.3
-
60
-
-
3042523481
-
Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway
-
Jun 15
-
Bian D, Su S, Mahanivong C, et al. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway. Cancer Res. Jun 15 2004;64(12):4209-4217.
-
(2004)
Cancer Res
, vol.64
, Issue.12
, pp. 4209-4217
-
-
Bian, D.1
Su, S.2
Mahanivong, C.3
-
61
-
-
15744399854
-
Geranylgeranylacetone inhibits lysophosphatidic acid-induced invasion of human ovarian carcinoma cells in vitro
-
Apr 1
-
Hashimoto K, Morishige K, Sawada K, et al. Geranylgeranylacetone inhibits lysophosphatidic acid-induced invasion of human ovarian carcinoma cells in vitro. Cancer. Apr 1 2005;103(7):1529-1536.
-
(2005)
Cancer
, vol.103
, Issue.7
, pp. 1529-1536
-
-
Hashimoto, K.1
Morishige, K.2
Sawada, K.3
-
62
-
-
0036827799
-
Alendronate inhibits lysophosphatidic acidinduced migration of human ovarian cancer cells by attenuating the activation of rho
-
Nov 1
-
Sawada K, Morishige K, Tahara M, et al. Alendronate inhibits lysophosphatidic acidinduced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer Res. Nov 1 2002;62(21):6015-6020.
-
(2002)
Cancer Res
, vol.62
, Issue.21
, pp. 6015-6020
-
-
Sawada, K.1
Morishige, K.2
Tahara, M.3
-
63
-
-
33751423848
-
S1P regulation of ovarian carcinoma invasiveness
-
Dec
-
Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman DA. S1P regulation of ovarian carcinoma invasiveness. Gynecol Oncol. Dec 2006;103(3):952-959.
-
(2006)
Gynecol Oncol
, vol.103
, Issue.3
, pp. 952-959
-
-
Smicun, Y.1
Reierstad, S.2
Wang, F.Q.3
Lee, C.4
Fishman, D.A.5
-
64
-
-
35348894030
-
S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells
-
Nov
-
Smicun Y, Gil O, Devine K, Fishman DA. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells. Gynecol Oncol. Nov 2007;107(2):298-309.
-
(2007)
Gynecol Oncol
, vol.107
, Issue.2
, pp. 298-309
-
-
Smicun, Y.1
Gil, O.2
Devine, K.3
Fishman, D.A.4
-
65
-
-
34548442406
-
Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: Involvement of pertussis toxin-sensitive G-protein coupled receptor
-
Sep 18
-
Park KS, Lee HY, Lee SY, et al. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. FEBS Lett. Sep 18 2007;581(23):4411-4416.
-
(2007)
FEBS Lett
, vol.581
, Issue.23
, pp. 4411-4416
-
-
Park, K.S.1
Lee, H.Y.2
Lee, S.Y.3
|